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Abstract
Background: The Influenza A pandemic H1N1 2009 (H1N1pdm) virus appeared in India in May 2009 and thereafter
outbreaks with considerable morbidity and mortality have been reported from many parts of the country. Continuous
monitoring of the genetic makeup of the virus is essential to understand its evolution within the country in relation to
global diversification and to track the mutations that may affect the behavior of the virus.
Methods: H1N1pdm viruses were isolated from both recovered and fatal cases representing major cities and sequenced.
Phylogenetic analyses of six concatenated whole genomes and the hemagglutinin (HA) gene of seven more isolates from
May-September 2009 was performed with reference to 685 whole genomes of global isolates available as of November 24,
2009. Molecular characterization of all the 8 segments was carried out for known pathogenic markers.
Results: The first isolate of May 2009 belonged to clade 5. Although clade 7 was the dominant H1N1pdm lineage in India,
both clades 6 and 7 were found to be co-circulating. The neuraminidase of all the Indian isolates possessed H275, the
marker for sensitivity to the neuraminidase inhibitor Oseltamivir. Some of the mutations in HA are at or in the vicinity of
antigenic sites and may therefore be of possible antigenic significance. Among these a D222G mutation in the HA receptor
binding domain was found in two of the eight Indian isolates obtained from fatal cases.
Conclusions: The majority of the 13 Indian isolates grouped in the globally most widely circulating H1N1pdm clade 7.
Further, correlations of the mutations specific to clade 7 Indian isolates to viral fitness and adaptability in the country
remains to be understood. The D222G mutation in HA from isolates of fatal cases needs to be studied for pathogenicity.
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Introduction
The first influenza pandemic of the 21st century was declared
with the emergence of a novel Influenza A (H1N1) strain in
Mexico and the USA in April 2009 [1]. The virus has been
detected in about 207 countries infecting more than 622,482
people worldwide with more than 7,820 deaths as of November
22, 2009 [2]. The virus was first detected in India in May 2009 [3].
Since then outbreaks have been reported from many parts of the
country. As of December 6, 2009, the total number of confirmed
cases in India was 19,632 with 621 deaths [4].
Several reports describe both the emergence and the pandemic
potential of the virus in the perspective of prior pandemic
influenza viruses of 1918 (H1N1), 1957 (H2N2) and 1968 (H3N2)
[5,6] by comparison of the available genetic sequence data. The
genetic analysis of the novel H1N1 virus isolated from a patient in
California revealed that it was a recent reassortant of gene
segments from both the North American and Eurasian swine
lineages [7]. It was determined that the virus possesses the
polymerase basic-2 (PB2) and polymerase A (PA) genes of North
American avian virus origin, the polymerase basic-1 (PB1) gene
of human H3N2 virus origin, the hemagglutinin (HA), nuclear
protein (NP) and non-structural (NS) genes of classical swine
origin and the neuraminidase (NA) and matrix (M) genes of
Eurasian swine virus origin. The human-like PB1 gene and
avian-like PB2 and PA genes however have been circulating
in pigs since 1997–98 in the form of a triple reassortant swine
virus [8]. Certain specific molecular markers predictive of
adaptation to human were found to be absent in the pandemic
H1N1 2009 (H1N1pdm) viruses suggesting that, previously
unrecognized molecular determinants could be responsible for
the transmission among human [7]. Other reports comparing the
HA gene sequence with those of the earlier influenza pandemics
have shown that human-specific markers supporting efficient
transmissibility of these viruses in human are present in the
H1N1pdm virus [9,10]. The amino acids in the active site of NA
suggest susceptibility [7] to Oseltamivir and Zanamivir type
inhibitors, though, in view of the extensive use of these antivirals
the emergence of drug-resistant variants is a matter of serious
concern. Further, continuous monitoring of the evolution of this
virus is advocated to track the mutations that may increase
pathogenicity and/or transmissibility.
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A recent study [11] revealed that the early diversification of the
H1N1pdm virus based on concatenated whole genomes resulted
into seven lineages, clade 1–7, that showed defined spatial
patterns. Understanding the virus evolution within India in
relation to global diversification of the virus is also essential. In
this study, we present the analysis of whole genome sequences of
six Indian isolates and the HA gene sequences from another seven
isolates for genetic characterization and comparison with global
isolates.
Results
The first isolate from India (A/India-Hyd/NIV51/2009) was
from a traveler reaching Hyderabad on May 13, 2009 from the
USA. Positive cases of H1N1pdm virus were thereafter detected
from major cities (Pune, Delhi, Mumbai, Chennai and Bangalore)
with maximum fatality reported from Pune and Bangalore [4].
Selected samples were processed for virus isolation. Isolates
representing different geographical regions, disease severity and
time points between May-September 2009 were sequenced
(Table 1).
Phylogenetic analysis
Sequence analysis of the whole genome of the six Indian isolates
revealed .99% nucleotide identity with the A/California/04/
2009 (H1N1) prototype strain in all the gene segments. Similarly,
99.06% amino acid identity was noted in the HA of the Indian
isolates with respect to A/California/04/2009. The percent amino
acid divergence (PAD) within each gene segment of the six Indian
isolates ranged from 0% (in PB2 and M) to 0.66% (in HA) while
the PAD within the HA genes of the 13 isolates was 0.5860.17%.
Phylogenetic analysis of the six concatenated whole genome
sequences was performed along with the whole genomes of global
isolates available in the GenBank. In an earlier concatenated
whole genome analysis of 240 H1N1pdm virus isolates up to July
2009 [11], seven discrete clades of the H1N1pdm viruses
circulating globally were observed. In the present study, the
analysis was performed with an enhanced data set (n = 685) as of
November 24, 2009. Clade 1 included amongst others the
California/04/2009 and California/07/2009 isolates while Clade
2 included isolates from Mexico, California, Canada, France,
Germany, Netherlands, China and multiple US states; clade 3 -
France, England, Russia, China, Canada, Mexico and the US
states; clade 4–two east Asian countries, Korea and Japan; clade
5–Canada, China, Japan, the USA (mainly Wisconsin isolates)
with an addition of Thailand and clade 6–Canada, Italy, China,
Japan with new additions of Germany, Taiwan, Thailand and few
US states. The clade 7 which was the largest clade included
isolates from Canada, China, Japan, Germany, Italy, Luxem-
bourg, Russia and several states of the USA with Taiwan,
Denmark, Singapore, Malaysia, Central and South America
getting added. Figure 1 depicts the concatenated whole genome
phylogeny based on 96 isolates representative of different
geographical regions along with the genomes of the Indian isolates.
As seen in figure 1 the Indian isolates belonged to three different
clades. The earliest Indian isolate (A/India-Hyd/NIV51/2009) of
May 2009 clustered with clade 5 isolates, one Indian isolate (A/
India-Pune/NIV6196/2009) of mid August belonged to clade 6 while
four Indian isolates (A/India-Blore/NIV236/2009, A/India-Blore/
NIV310/2009, A/India-Pune/NIV6447/2009, A/India-Pune/8489/
2009) of the period from June end to August 2009 clustered into
clade 7.
HA-based phylogenetic analysis was also performed for the 13
Indian isolates with reference to the HA genes of the 685 global
whole genomes. Though the clade assignment is based on con-
catenated whole genomes, notably in the HA gene phylogeny, the
topology of the clades 6 and 7 was maintained. However, some
minor changes were observed in the topology of the other clades.
Figure 2 shows the HA-based Bayesian phylogeny considering the
13 Indian isolates and a few representative isolates of other clades.
Except for A/India-Hyd/NIV51/2009, all the other Indian isolates
clustered into clades 6 and 7 with strong bootstrap support. The A/
India-Pune/NIV6196/2009 isolate maintained its position in clade
6 and so also the other four isolates retained their positions in clade
7. Of the seven additional Indian isolates, one isolate of September
(A/India-Pune/NIV10604/2009) belonged to clade 6 while the
remaining six isolates (A/India-Pune/NIV9355/2009, A/Delhi/
NIV3610/2009, A/India-Mum/NIV5442/2009, A/India-Mum/
NIV9945/2009, A/India-Pune/NIV10278/2009, A/India-Delhi/
NIV3704/2009) of the period from August to September 2009
Table 1. Details of patients and H1N1pdm viruses isolated during May–September 2009.
Sr
No. Name of the Isolate
Date of
Collection
Location of
the patient
Age
(yr/mth) Sex
Status of
patient Genes sequenced
1 A/India-Hyd/NIV51/2009 13 May 2009 Hyderabad 23 yr M Recovered PB2, PB1, PA, HA, NP, NA, M, NS
2 A/India-Blore/NIV236/2009 26 June 2009 Bangalore 2.5 yr M Recovered PB2, PB1, PA, HA, NP, NA, M, NS
3 A/India-Blore/NIV310/2009 01 July 2009 Bangalore 9 yr F Recovered PB2, PB1, PA, HA, NP, NA, M, NS
4 A/India-Pune/NIV6196/2009 16 August 2009 Pune 17 yr M Death PB2, PB1, PA, HA, NP, NA, M, NS
5 A/India-Pune/NIV6447/2009 17 August 2009 Pune 22 yr F Death PB2, PB1, PA, HA, NP, NA, M, NS
6 A/India-Pune/NIV8489/2009 22 August 2009 Pune 42 yr F Death PB2, PB1, PA, HA, NP, NA, M, NS
7 A/India-Delhi/NIV3610/2009 13 August 2009 Delhi 12 yr M Recovered HA
8 A/India-Mum/NIV5442/2009 16 August 2009 Mumbai 2 mth F Death HA
9 A/India-Pune/NIV9355/2009 29 August 2009 Pune 20 yr M Death HA
10 A/India-Mum/NIV9945/2009 3 Sept. 2009 Mumbai NA M Death HA
11 A/India-Pune/NIV10278/2009 7 Sept. 2009 Pune 6 yr M Death HA
12 A/India-Delhi/NIV3704/2009 8 Sept. 2009 Delhi 13 yr M Recovered HA
13 A/India-Pune/NIV10604/2009 10 Sept. 2009 Pune 3 yr F Death HA
doi:10.1371/journal.pone.0009693.t001
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clustered into clade 7. No spatial or temporal patterns within the
Indian isolates of clade 7 could be observed.
Mutations noted in the Indian isolates with respect to the
prototype isolate (A/California/04/2009) are shown in Tables 2
and 3. The clade specific mutations [11] in different genes, NP:
V100I; NA: V106I and N248D; HA: K-15E (K2E), Q293H
(Q310H) and S203T (S220T); NS1: I123V, were also noted
amongst the Indian isolates. The residue position within
parenthesis for the HA is the numbering considered inclusive of
the signal peptide. Additionally, mutations P83S (P100S) and
Figure 1. Phylogenetic tree of concatenated whole genomes of 6 Indian isolates and representative global isolates using the
Neighbor-joining method. Scale bar indicates number of nucleotide substitutions per site.
doi:10.1371/journal.pone.0009693.g001
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I321V (I338V) in HA along with P224S in PA present in the
Indian isolates have been observed in all the non-clade1 isolates
[11]. Mutations S451N and I547T in the HA, T232P in the PB1
were unique to Indian isolates, the significance of which need to be
addressed. The PB2 region of all the Indian isolates did not have
any mutation.
Molecular characterization
HA of the Indian isolates, as in other H1N1pdm viruses
possessed D190 in the receptor binding site, which is known to
confer binding of H1 viruses to human receptors [12] probably,
supporting the efficient transmissibility of these viruses in human
[9]. The majority of Indian isolates, (11 of 13) as well as H1N1pdm
viruses, possessed D225 [12] in the receptor binding domain
(RBD), though two of the Indian isolates (A/Pune/NIV9355/
2009, A/India-Pune/NIV10278/2009) had D225G (D222G as
per H1N1pdm numbering). Notably, this mutation was observed
in the isolates from two fatal cases of the later period (late August -
and September). Among other critical residues [13] known to
confer human specificity in H5 viruses, E227, P221 and E216 were
also noted in H1N1pdm viruses including the Indian isolates. Key
residues in the RBD [13] predicted to have a role in binding to
Figure 2. HA gene phylogeny of 13 Indian isolates and representative global isolates using the Bayesian method. Scale bar indicates
number of nucleotide substitutions per site. The color scheme follows that of Figure 1. Scale bar indicates number of nucleotide substitutions per
site.
doi:10.1371/journal.pone.0009693.g002
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human receptors (T98Y, S136T, 153W, 183H) were found to be
Y98, S136, W153 and H183 in the Indian isolates as in other
H1N1pdm viruses. The majority of H1N1pdm viruses, including
the Indian isolates, had eight putative glycosylation sites at
positions 27, 28, 40, 104, 293, 304, 498 and 557. They also
possessed a single basic amino acid at the HA cleavage site instead
of the polybasic cleavage site of highly pathogenic H5 and H7
viruses [14].
Mapping of the HA mutations observed in the Indian isolates
(Table 3) on to the known antigenic sites of H1 [15] and H3 [16]
was carried out. Mutation P83S observed in all the Indian isolates
was located in the antigenic site E, while mutation K154E of A/
India-Delhi/NIV3610/2009 was located in site B. Both the
mutations D222G (A/India-Pune/NIV9355/2009, A/India-
Pune/NIV10278/2009) and Q223R (A/India-Blore/NIV236/
2009) were located in site D (vicinity of Ca1). Further, mutations
T197A, Q293H and both S203T, V234I were found to be in the
vicinity of site B (Cb), site C and site D (Ca1), respectively.
All the Indian isolates possessed residue H274 (position 275 in
N1 numbering) a known marker for sensitivity to the neuramin-
idase inhibitor, Oseltamivir [17]. The H1N1pdm viruses including
the Indian isolates had the genetic marker S31N in the M2 gene
[18] suggesting Amantadine resistance. In the PB2 gene, the
Indian and all other isolates of H1N1pdm possessed the low
pathogenic markers, E627 [19] and D701 [20]. The PB1-F2
protein, which has been associated with the increased pathoge-
nicity of the 1918 H1N1 virus and other highly pathogenic H5N1
viruses [21], is truncated in all H1N1pdm viruses, and is so also in
the Indian isolates, due to stop codons at positions 12, 58 and 88.
In the NS1 protein, the mutation D92E known for high virulence
in human [22] is absent in all H1N1pdm viruses, as well as the
Indian isolates. The PDZ ligand domain at the C-terminus of NS1
implicated in pathogenicity of the 1918 H1N1 virus [23] is absent,
as all the H1N1pdm viruses and the Indian isolates had a
truncated NS1 due to the presence of a stop codon at position 220.
A recent study [10] revealed that out of the 47 signatures that
separate the avian viruses from human viruses by their non-
glycoproteins, eight (PB2- A271; PB1- I336; PA- R356, N409;
NP- I33, V100, K305, K357) were human-like in the H1N1pdm
viruses. The Indian isolates showed all these signatures except
V100 in NP.
Discussion
Diversity of the Indian isolates at the amino acid level with
respect to the prototype strain and within the Indian isolates was
found to be maximum in the HA gene. In the concatenated whole
genome-based phylogenetic analysis, with the enhanced data set in
this study, no diversification beyond the existing seven clades [11]
was observed. The two mutations in HA, K-15E and Q293H
specific to clade 6 isolates and one mutation S203T specific to
clade 7 isolates was adequate to delineate these two clades in the
HA-based phylogeny. Phylogenetic analysis of the six whole
genomes from India demonstrated that the earliest isolate of May
2009 from Hyderabad was a clade 5 isolate. This correlates to the
time during which the global dissemination of the pandemic
H1N1 virus was noted in Asian countries [11]. A movement of
clade 5 virus was reported in Asia during week 8 (week 1 beginning
April 1, 2009, the date of collection of the first H1N1pdm isolate).
Notably, our first isolate represents an introduction of the virus in
week 7. Incidentally, there were no isolates belonging to clade
5 during the weeks 9–11 in any Asian country. The observation
that no other Indian isolate considered in this study belonged
to this clade suggests that either the propagation of this strain
was curtailed due to control measures or the fitness of the
clade itself was questionable. Two isolates of India of the period
Table 2. Mutations in the gene segments of the six whole genomes of H1N1pdm Indian isolates with respect to A/California/04/
2009.
Gene
segment
Residue
Number
A/California/
04/2009 Clade 5 Clade 6 Clade 7
A/India-Hyd/
NIV51/2009
A/India-Pune/
NIV6196/2009
A/India-Blore/
NIV236/2009
A/India-Blore/
NIV310/2009
A/India-Pune/
NIV6447/2009
A/India-Pune/
NIV8489/2009
PB1 61 T . . . . . I
254 F L L . . . .
PA 28 P Q . . . . .
224 P S S S S S S
271 P . R . . . .
581 M . . . . L .
NP 100 V I I I I I I
232 T P . P . P .
NA 30 I V V V . V .
106 V I I I I I I
189 N . S . . . .
248 N D D D D D D
256 F . . V . . .
NS1 28 G . S . . . .
123 I . . V V V .
154 G . . . . . R
NS2 115 A T . . . . .
doi:10.1371/journal.pone.0009693.t002
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August-September from Pune belonged to clade 6, both of which
were from fatal cases. Though both these cases were not directly
associated with any foreign travel history, it cannot be determined
whether the clade evolved within the country or was again
introduced into the country. All the other 10 Indian isolates
belonged to clade 7 which has been the predominantly circulating
clade since week 9 in Asia [11]. Two of our earliest isolates
belonging to this clade of week 13–14 (June end–July 1) namely A/
India-Blore/NIV236/2009 and A/India-Blore/NIV310/2009
from Bangalore had a history of foreign travel and thus may be
indicative that the clade 7 was introduced from an external source.
The isolates of six fatal cases in this study belonged to clade 7,
though none were associated with the known markers indicative of
increased pathogenicity in any of the genes.
The D222G mutation observed in two of the Indian isolates of
clade 7 was also noted in twelve other H1N1pdm global isolates in
GenBank at different time points during April–September, 2009.
As reported earlier [10,13], the two variants D and G at this
position were also observed during the 1918 pandemic. Glycan
microarray studies [13] have shown that HA possessing D190
along with G225 (G222 in H1N1pdm numbering) had specificity
for both alpha 2, 3 and alpha 2, 6 linkages with no difference in
virulence or transmissibility. Although the D222G mutation in the
Indian isolates was from fatal cases, there were six other fatal cases
having D222. Thus, the significance of this mutation in terms of
pathogenicity needs to be verified.
Among the established pathogenic markers, no significant
change was observed in the Indian isolates when compared to
other H1N1pdm viruses. Of the mutations in HA, several of the
changes were at or in the vicinity of the known antigenic sites and
may therefore be of antigenic significance and have subsequent
implications to vaccine efficacy. Further, the importance of the
specific mutations observed in clade 7 and also in the Indian
isolates needs further attention.
Overall, the analysis carried out in this study indicated that the
dominant H1N1pdm lineage in India is clade 7, though both
clades 6 and 7 are in co-circulation. Whether the predominance of
clade 7 in India is related to the fitness and adaptability of the virus
and more efficient human transmissibility requires further
investigation in order to be understood.
Materials and Methods
The clinical materials (throat and nasal swabs) obtained from
patients were inoculated in specific pathogen-free (SPF) embryo-
nated White Leghorn chicken eggs and Madin Darby Canine
Kidney (MDCK) cell lines for isolation of the virus [24,25]. Tissue
culture fluid or allantoic fluid was harvested after observing
inoculated eggs/MDCK cell line for cytopathic effect. All the
samples were processed in the enhanced Biosafety level (BSL-2+)
laboratory. Hemagglutination and Hemagglutination Inhibition
(HAI) tests were performed using Guinea pig and fowl RBC as
described earlier [26].
RNA was extracted from 140 ml of tissue culture fluid or
allantoic fluid of each sample using QIAmp viral RNA mini kit
(Qiagen, Germany) according to the manufacturer’s specifications.
One step RT-PCR was carried out to amplify all the eight
segments using the recommended WHO-CDC whole genome
primers [27]. Each of the segments were amplified in three to four
fragments of 400 to 550 bp with 100 bp overlap in order to get at
least four fold sequence coverage. To amplify each segment, 5 ml
of RNA was added to 50 ml of master mix containing 25 ml of 2X
enzyme buffer, 2 ml Invitrogen Superscript III enzyme, 1 ml of
each reverse and forward primers, 1 ml RNasin (Promega, USA)
and 15 ml molecular grade water. The reaction conditions were
reverse transcription at 55uC for 40 min, initial denaturation at
94uC for 3 min followed by 35 cycles of 94uC for 30 sec, 50uC for
1 min, 68uC for 1 min with a final extension at 68uC for 5 min.
The resulting amplicons for all the eight segments were
analyzed by 1% agarose gel electrophoresis. The expected size
products that appeared as single bands were purified directly using
PCR purification kits (Qiagen), whereas using Gel extraction kit
(Qiagen) in case of multiple bands. DNA sequencing was carried
out using Big Dye terminator V 3.1 cycle sequencing ready
reaction kit (ABI, Foster City, CA) together with corresponding
internal primers (WHO full genome sequencing primers) which
were designed denovo to ensure specificity for each sequence.
Subsequently, any unincorporated labeled dNTP’s were removed
using Dye-X removal column purification kit (Qiagen). The
sequencing was done on ABI 3730 DNA analyzer and sequences
were curated using sequencing analysis version 5.3 and MEGA
version 4 was used for sequence alignment.
Whole genome of six isolates representing 3 recovery cases (A/
India-Hyd/NIV51/2009, A/India-Blore/NIV236/2009, A/India-
Blore/NIV310/2009) with travel history from an endemic country
and 3 fatal cases (A/India-Pune/NIV6196/2009, A/India-Pune/
NIV6447/2009, A/India-Pune/NIV8489/2009) were sequenced.
Additionally, the HA gene of seven other cases were sequenced
which represent 2 recovered cases (A/India-Delhi/NIV3610/2009,
A/India-Delhi/NIV3704/2009) and 5 fatal cases (A/India-Mum/
NIV5442/2009, A/India-Pune/NIV9355/2009, A/India-Mum/
NIV9945/2009, A/India-Pune/NIV10278/2009, A/India-Pune/
NIV10604/2009). The GenBank accession numbers of the six
whole genome sequences and 7 additional HA gene sequences of
the period May–September 2009 are from GU292344-98.
For phylogenetic analysis, the eight segments of the six whole
genomes of the Indian isolates were concatenated and compared
with 685 concatenated whole genome sequences available in
GenBank as of November 24, 2009. MEGA version 4 [28] was
used for constructing neighbor-joining (NJ) trees using the Kimura’s
two-parameter distance model with 1000 bootstrap replicates. The
percent nucleotide identity (PNI) and percent amino acid identity
(PAI) values were calculated as pairwise p-distances. The HA-based
phylogenetic tree was constructed using the NJ method and the tree
topology was further confirmed by using the Bayesian approach as
implemented in Mr Bayes 3.2 [29]. The General Time Reversible
(GTR) + Invariable sites (I) model with gamma-distributed rate
variation across sites and a proportion of invariable sites was
specifically used with other parameters kept at default.
For molecular characterization, the mutations in all the eight
gene segments of Indian isolates were compared to the established
human pathogenic markers of H1/H5 viruses. The four antigenic
sites in HA designated Sa, Sb, Ca1/Ca2 and Cb identified on the
A/PR/8/34(H1N1) virus [15] as well as antigenic sites A, B, C, D
and E in H3 [30,31] mapped on H1 [16] were used for identifying
the antigenic sites of H1N1pdm Indian isolates. The NetNGlyc 1.0
Server [32] was used for the prediction of putative glycosylation
sites in HA.
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